Neoadjuvant treatment is always justified for small PDAC, especially for clinical T1? Debate from the position of Cons

Hi ,  oki YAMAUE

Annals of Hepato-Biliary-Pancreatic Surgery

2021 .12

Neoadjuvant treatment is always justified for small PDAC, especially for clinical T1? - Debate from the position of Pros

Jin-Seok HEO

Annals of Hepato-Biliary-Pancreatic Surgery

2021 .12

Clinical Significance of Surgical Margins in Distal Pancreatectomy for PDAC

Gowon Choi ,  Mi ,  ang Lee 외 6명

대한외과학회 학술대회 초록집

2022 .05

Analysis of CfDNA for diagnosis and prognostic prediction in PDAC patients

Wenhui LOU

Annals of Hepato-Biliary-Pancreatic Surgery

2022 .12

Clinical benefit of neoadjuvant treatment for borderline resectable PDAC based on RCT

Seong-Ho Choi

한국간담췌외과학회 학술대회지

2017 .03

Response to Neoadjuvant Therapy and Prognosis in Patients with Resectable Pancreatic Cancer: A Propensity Score Matching Analysis

Yoon Min Sung ,  Lee Hee Seung ,  Kang Chang Moo 외 15명

Gut and Liver

2022 .01

Analysis of Molecular Pathways in Pancreatic Ductal Adenocarcinomas with a Bioinformatics Approach

Wang ,  Yan ,  Li 외 1명

Asian Pacific journal of cancer prevention : APJCP

2015 .01

Exploring the prognostic role of cluster of differentiation 47 in patients with advanced pancreatic cancer: a comparative cohort study

Eden Deme ,  e Ama ,  e 외 7명

Annals of Surgical Treatment and Research

2025 .02

Identification of ANXA1 as a Lymphatic Metastasis and Poor Prognostic Factor in Pancreatic Ductal Adenocarcinoma

Liu ,  Qing-Hua ,  Shi 외 5명

Asian Pacific journal of cancer prevention : APJCP

2015 .01

The effects of systemic inflammatory response on prognosis of pancreatic ductal adenocarcinoma

Ali Aktekin ,  Mehmet To ,  un 외 5명

Annals of Hepato-Biliary-Pancreatic Surgery

2019 .05

Artery first approach pancreaticoduodenectomy with segmental resection and reconstruction of SMV for borderline resectable PDAC after neoadjuvant chemotherapy

Yinmo YANG

Annals of Hepato-Biliary-Pancreatic Surgery

2022 .12

Development and External Validation of Survival Prediction Model for Pancreatic Cancer Using Two Nationwide Databases: Surveillance, Epidemiology and End Results (SEER) and Korea Tumor Registry System-Biliary Pancreas (KOTUS-BP)

Kang Jae Seung ,  Mok Lydia ,  Heo Jin Seok 외 30명

Gut and Liver

2021 .11

Diagnostic model for pancreatic cancer using a multi-biomarker panel

Yoo Jin Choi ,  Woongchang Yoon ,  A 외 23명

Annals of Surgical Treatment and Research

2021 .03

Comparison of perioperative outcomes in pancreatic head cancer patients following either a laparoscopic or open pancreaticoduodenectomy with a superior mesenteric artery first approach

Min Young Pa ,  k ,  Woohyung Lee 외 5명

Annals of Hepato-Biliary-Pancreatic Surgery

2021 .08

Clinical significance of C-reactive protein-to-prealbumin ratio in predicting early recurrence in resectable pancreatic cancer

Chae Hwa Kwon ,  Hyung Il Seo ,  Dong Uk Kim 외 8명

KOREAN JOURNAL OF CLINICAL ONCOLOGY

2023 .06

Efficacy of Capecitabine Plus Oxaliplatin Combination Chemotherapy for Advanced Pancreatic Cancer after Failure of First-Line Gemcitabine-Based Therapy

청광현 ,  류지곤 ,  손준혁 외 4명

Gut and Liver

2017 .01

Novel Drug Screening Platform: Tumor Organoid

맹주은 ,  서하영 ,  김순찬 외 1명

대한췌담도학회지

2021 .10

Pancreatic duct lavage cytology combined with a cell-block method for patients with possible pancreatic ductal adenocarcinomas, including pancreatic carcinoma in situ

Hi ,  oaki Kusunose ,  Shinsuke Koshita 외 15명

Clinical Endoscopy

2023 .05

Risk Stratification of Pancreatic Ductal Adenocarcinoma Patients Undergoing Curative-Intent Surgery after Neoadjuvant Therapy

양현경 ,  박미숙 ,  한경화 외 7명

Cancer Research and Treatment

2024 .01

Advances in neoadjuvant therapy for resectable pancreatic cancer over the past two decades

Alva ,  o G ,  ego 외 15명

Annals of Hepato-Biliary-Pancreatic Surgery

2021 .05